671 related articles for article (PubMed ID: 32398949)
21. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
Zou Y; Jiang G; Xie Y; Li H
Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
[TBL] [Abstract][Full Text] [Related]
22. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
23. The essential roles of m
Ma L; Xue X; Zhang X; Yu K; Xu X; Tian X; Miao Y; Meng F; Liu X; Guo S; Qiu S; Wang Y; Cui J; Guo W; Li Y; Xia J; Yu Y; Wang J
J Exp Clin Cancer Res; 2022 Jan; 41(1):36. PubMed ID: 35078505
[TBL] [Abstract][Full Text] [Related]
24. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma.
Liu J; Zheng Z; Zhong J
J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144
[TBL] [Abstract][Full Text] [Related]
25. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
26.
Mo P; Xie S; Cai W; Ruan J; Du Q; Ye J; Mao J
J Int Med Res; 2020 Sep; 48(9):300060520951405. PubMed ID: 32972288
[TBL] [Abstract][Full Text] [Related]
27. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M
BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068
[TBL] [Abstract][Full Text] [Related]
28. Gene Signature and Identification of Clinical Trait-Related m
Hou J; Wang Z; Li H; Zhang H; Luo L
Front Genet; 2020; 11():522. PubMed ID: 32754191
[TBL] [Abstract][Full Text] [Related]
29. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Jiang H; Ning G; Wang Y; Lv W
Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
[TBL] [Abstract][Full Text] [Related]
30. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
Xu LC; Pan JX; Pan HD
Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
32. N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer.
Wu Q; Xie X; Huang Y; Meng S; Li Y; Wang H; Hu Y
J Cancer; 2021; 12(3):682-692. PubMed ID: 33403026
[TBL] [Abstract][Full Text] [Related]
33. Construction and validation of m
Miao Y; Su B; Tang X; Wang J; Quan W; Chen Y; Mi D
IET Syst Biol; 2022 Apr; 16(2):59-71. PubMed ID: 35174637
[TBL] [Abstract][Full Text] [Related]
34. The role of m
Chen XY; Zhang J; Zhu JS
Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
[TBL] [Abstract][Full Text] [Related]
35. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
36. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
[TBL] [Abstract][Full Text] [Related]
37. An N
Chu X; Wang W; Sun Z; Bao F; Feng L
Math Biosci Eng; 2022 Jan; 19(1):253-270. PubMed ID: 34902990
[No Abstract] [Full Text] [Related]
38. Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration.
Hu K; Yao L; Yan Y; Zhou L; Li J
Dis Markers; 2021; 2021():2789481. PubMed ID: 34497675
[TBL] [Abstract][Full Text] [Related]
39. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
Miao C; Fang X; Chen Y; Zhao Y; Guo Q
Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221
[TBL] [Abstract][Full Text] [Related]
40. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]